THE BOLD NEW CHOICE

FOR CHRONIC PAIN RELIEF

At Abbott, we understand the heavy burden chronic pain creates. We know pain has more than the power to limit your life; it has the power to take over your life.

Today, there is a bold new choice for chronic pain relief — the Proclaim™ XR recharge-free SCS system.

Combined with the power of BurstDR™ stimulation therapy, the Proclaim XR SCS system is our latest advancement in neurostimulation therapy (also called SCS). With the Proclaim XR SCS system, you can now have hassle-free pain relief with a battery that lasts up to 10 years at low-dose settings* without ever needing to charge the system.

It’s time to stop watching life go by and start living XR.

WHY PROCLAIM XR

IT'S TIME TO

LIVE XR

SCS therapy is a well-established pain treatment used by doctors for more than 50 years.

One of our most advanced forms of this therapy is BurstDR stimulation, available on the Proclaim XR SCS system.

It’s life-changing technology right at your fingertips.

HOW IT WORKS

BE BOLD. LIVE XR.

Ask your doctor for the Proclaim XR SCS system. The bold choice in chronic pain relief in a system that lasts up to 10 years at low-dose settings* without the hassle of recharging.

FIND A DOCTOR START YOUR JOURNEY

ALREADY USING SCS

FOR CHRONIC PAIN?

For some, traditional tonic stimulation provides pain relief at first, but stops working over time. Others report feeling tingling sensations1 or grow tired of the need to keep recharging their system.

Answer this series of questions to help you identify whether you’re getting the most out of your current neurostimulation system.

ASSESS YOUR CURRENT SYSTEM

REFERENCES:

*Up to 10 years of battery longevity at the lowest dose setting: 0.6mA, 500 Ohms, duty cycle 30s on/360s off. NOTE: In neurostimulation therapy, ‘dose’ refers to the delivery of a quantity of energy to tissue. Safety comparisons and specific dose-response curves for each dosage have not been clinically established. Refer to the IFU for additional information. Hassle-free means recharge-free.

1. Hayek SM, Veizi E, Hanes M. (2015). Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database. Neuromodulation: Technology at the Neural Interface. (N=345)

Important Safety Information

SJM-PXR-0919-0035